Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones All 115 patients implanted in DREAM U.S. pivotal study First DREAM PMA module submitted First patient implanted in ACCCESS U.S. pivotal study Mont-Saint-Guibert, Belgium – March 6, 2023, 7:30am CET / 1:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), […]
Continue Reading